Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Stopped Slow recruitment

Conditions

• Type 2 Diabetes
• Nonalcoholic Steatohepatitis

Interventions

• DRUG: sitagliptin
• DRUG: placebo

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

• [object Object]